Mirjam Boelens to Cohort Studies
This is a "connection" page, showing publications Mirjam Boelens has written about Cohort Studies.
Connection Strength
0.054
-
Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +/- binimetinib or alpelisib. Br J Cancer. 2021 01; 124(1):176-182.
Score: 0.030
-
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2ß. Lab Invest. 2018 01; 98(1):117-129.
Score: 0.024